Jazz Pharma Plc (JAZZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,355,802 | 1,443,385 | 1,506,310 | 1,335,690 | 1,282,304 |
| Marketable Securities | 625,000 | 375,000 | 120,000 | 250,000 | 80,000 |
| Receivables | 698,037 | 707,095 | 705,794 | 627,841 | 610,389 |
| Inventories | 542,555 | 577,321 | 597,039 | 611,827 | 657,214 |
| Other current assets | 325,851 | 314,535 | 320,809 | 310,404 | 272,458 |
| TOTAL | $3,681,666 | $3,539,898 | $3,435,428 | $3,245,752 | $3,009,855 |
| Non-Current Assets | |||||
| PPE Net | 169,281 | 166,236 | 169,646 | 222,476 | 229,264 |
| Intangibles | 6,815,393 | 6,974,991 | 7,171,169 | 7,123,180 | 7,448,452 |
| Other Non-Current Assets | 695,528 | 645,950 | 617,116 | 612,657 | 572,970 |
| TOTAL | $7,680,202 | $7,787,177 | $7,957,931 | $7,958,313 | $8,250,686 |
| Total Assets | $11,361,870 | $11,327,080 | $11,393,360 | $11,204,070 | $11,260,540 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 605,798 | 605,375 | 604,954 | 604,507 | 31,000 |
| Accounts payable and accrued liabilities | 97,096 | 80,976 | 102,750 | 109,850 | 98,428 |
| Accrued Expenses | 800,993 | 826,530 | 793,914 | 769,942 | 748,304 |
| TOTAL | $1,556,025 | $1,562,206 | $1,536,692 | $1,573,329 | $945,265 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,100,983 | 5,105,111 | 5,107,988 | 5,110,757 | 5,686,646 |
| Deferred Revenues | N/A | N/A | N/A | 4 | 4 |
| Other Non-Current Liabilities | 167,033 | 153,583 | 163,976 | 189,372 | 192,230 |
| TOTAL | $6,043,244 | $6,068,408 | $6,119,670 | $6,141,363 | $6,789,600 |
| Total Liabilities | $7,599,269 | $7,630,614 | $7,656,362 | $7,714,692 | $7,734,865 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 61,754 | 63,040 | 62,345 | 62,957 | 63,135 |
| Common Shares | 61 | 61 | 61 | 61 | 61 |
| Retained earnings | 871,651 | 864,511 | 879,129 | 884,771 | 812,322 |
| Other shareholders' equity | -888,227 | -882,394 | -842,147 | -1,035,399 | -866,823 |
| TOTAL | $3,762,599 | $3,696,461 | $3,736,997 | $3,489,373 | $3,525,675 |
| Total Liabilities And Equity | $11,361,868 | $11,327,075 | $11,393,359 | $11,204,065 | $11,260,540 |